Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 5,854 | 5,011 | 3,971 | 3,440 | 0 |
| Cost of Goods | 1,864 | 2,143 | 1,411 | 1,304 | N/A |
| Gross Profit | 3,990 | 2,868 | 2,560 | 2,136 | N/A |
| Operating Expenses | 3,596 | 3,706 | 2,001 | 3,055 | 0 |
| Operating Income | 1,258 | -695 | 970 | -615 | N/A |
| Other Income | 58 | 5 | -5,462 | 13 | 0 |
| Pre-tax Income | 1,316 | -690 | -4,492 | -602 | 0 |
| Income Tax | 503 | 417 | N/A | N/A | N/A |
| Net Income Continuous | 813 | -1,107 | -4,492 | -602 | N/A |
| Net Income Discontinuous | N/A | N/A | -18 | 59 | N/A |
| Net Income | $813 | $-1,107 | $-4,510 | $-543 | $N/A |
| EPS Basic Total Ops | 0.15 | -0.44 | -0.66 | -0.05 | N/A |
| EPS Basic Continuous Ops | 0.10 | -0.09 | -0.36 | -0.05 | N/A |
| EPS Diluted Total Ops | 0.15 | -0.44 | -0.66 | -0.05 | N/A |
| EPS Diluted Continuous Ops | 0.10 | -0.09 | -0.36 | -0.05 | N/A |
| EBITDA(a) | $1,741 | $-392 | $1,218 | $-416 | $N/A |